APA (7th ed.) Citation

Z, G., F, Y., H, P., L, Z., W, L., R, L., . . . J, S. (2026). Very-low-dose decitabine and rhTPO for thrombocytopenia in lower-risk myelodysplastic syndrome. Annals of hematology, 105(5), . https://doi.org/10.1007/s00277-026-07023-y

Chicago Style (17th ed.) Citation

Z, Gao, et al. "Very-low-dose Decitabine and RhTPO for Thrombocytopenia in Lower-risk Myelodysplastic Syndrome." Annals of Hematology 105, no. 5 (2026). https://doi.org/10.1007/s00277-026-07023-y.

MLA (9th ed.) Citation

Z, Gao, et al. "Very-low-dose Decitabine and RhTPO for Thrombocytopenia in Lower-risk Myelodysplastic Syndrome." Annals of Hematology, vol. 105, no. 5, 2026, https://doi.org/10.1007/s00277-026-07023-y.